
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Acoustic neuroma secondary prevention
Introduction
Overview
Overview
Secondary prevention strategies following acoustic neuroma treatment include follow-up MRI scans.
Secondary Prevention
Secondary Prevention
The approach for follow-up studies after treatment and diagnosis is uncertain and there is not enough data to support specific recommendations. Due to the potentially slow growth of acoustic neuroma, prolonged follow-up is necessary.[1]
- Patients being managed with observation and with no tumor growth should be scanned yearly for 10 years and then every 3 – 5 years. Audiometry should also be performed on a regular basis.[2]
- A follow-up MRI is performed within 6 – 12 months after surgical excision to document complete tumor removal.
- Follow-up MRI should be obtained at 5 years and at 10 years, assuming complete tumor removal.
- If the findings on the 10-year follow-up MRI scan are normal, further imaging should be performed only if clinical circumstances require it.
- Patients treated with radiotherapy and with no tumor growth should be scanned yearly for 10 years and then every 2 years
References
References
- ↑ Jing Zou & Timo Hirvonen (2017). ““Wait and scan” management of patients with vestibular schwannoma and the relevance of non-contrast MRI in the follow-up”. Journal of otology. 12 (4): 174–184. doi:10.1016/j.joto.2017.08.002. PMID 29937853. Unknown parameter
|month=ignored (help) - ↑ Ian F. Dunn, Wenya Linda Bi, Srinivasan Mukundan, Bradley N. Delman, John Parish, Tyler Atkins, Anthony L. Asher & Jeffrey J. Olson (2018). “Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas”. Neurosurgery. 82 (2): E32–E34. doi:10.1093/neuros/nyx510. PMID 29309686. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
